Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

During a live event, Richard F. Riedel, MD, discussed key efficacy and safety outcomes from the phase 3 DeFi trial in ...

A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...

Glaxosmithkline Pharmaceuticals Ltd, Marico Ltd, Caplin Point Laboratories Ltd and Aarti Pharmalabs Ltd are among the other losers in the BSE's 'A' group today, 21 April 2025.

Highlights 54.8% Total Stockholder Return Under Refreshed Board and Management TeamZevra Continues Growth Trajectory into a ...

The following organizations have been chosen as Canada’s Greenest Employers for 2025 (employee count refers to full-time ...

Induced Nausea and Vomiting Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth ...

GlaxoSmithKline), a pleuromutilin approved in 2008; and tigecycline (Tygacil; Pfizer), a next-generation tetracycline approved in 2005. The reasons behind the decline in antibiotic research and ...

This FTSE 100 firm's smaller than rivals but could benefit from its big US manufacturing footprint and competitive market ...

Report Ocean (150+ country’s markets analyzed, function on 1,00000+ published and forthcoming reports every year.] presents a research report and top winning strategies for the “Frontotemporal ...